Thrombolytic Effect of Tissue Plasminogen Activator in a Cerebral Embolic Model
スポンサーリンク
概要
- 論文の詳細を見る
An experimental cerebral embolic model was prepared by an injection of [^<125>I] fibrin clot particles (20-100μm) into the left internal carotid artery in rats, and the changes in radioactivity of the brain were continuously monitored by a γ-ray detector. The autoradiograms of the caput transections showed the existence of emboli in small vessels of the left hemicerebrum. After the injection of [^<125>I] fibrin clots, the radioactivity spontaneously decreased to a half of the initial radioactivity at 90 min. The decrease in radioactivity which represented the embolus dissolution was markedly suppressed by an antiplasmin agent, trans-4-aminomethyl cyclohexane carboxylic acid, indicating that the endogenous fibrinolysis through the activation of fibrin clots caused a summation of the radioactivity and decreased the rate of dissolution at every embolus preparation. The thrombolytic agents were infused via the left internal carotid artery for 30 min after the second successive injection of fibrin clots. Although the spontaneous dissolution of emboli was observed during the infusion of saline, tissue plasminogen activator (t-PA) as well as urokinase plasminogen activator (u-PA) produced a further dissolution. Approximately half of the emboli disappeared 60 min after the infusion of t-PA at a dose of 75μg/kg and at a dose of 10000 IU/kg respectively.
- 公益社団法人日本薬学会の論文
著者
-
Koide T
Faculty Of Pharmaceutical Sciences Osaka University
-
Koide Takashi
Tokyo Research Laboratories Kowa Co. Ltd.
-
KANDA Hiroyasu
日産化学工業株式会社中央研究所
-
KIMATA Hideki
興和株式会社東京研究所
-
Kimata H
Kowa Company Ltd. Tokyo
-
Narita Tsutomu
Department Of Pediatrics Shiga University Of Medical Science
-
Narita T
Asahi Chemical Industry Co. Ltd. Miyazaki Jpn
-
KIMATA Hideki
Tokyo Research Laboratories, Kowa Co., Ltd.
-
NAKAJIMA Katsuaki
Tokyo Research Laboratories, Kowa Co., Ltd.
-
SUZUKI Hideo
Tokyo New Drug Research Laboratories I, Pharmaceutical Division, Kowa Co, Ltd
-
NARITA Tsutomu
Tokyo Research Laboratories, Kowa Co., Ltd.
-
Nakajima K
Tokyo Research Laboratories Kowa Co. Ltd.:asahi Chemical Industry Co. Ltd.
-
Nakajima Katsuaki
Tokyo Research Laboratories Kowa Company Ltd.
-
Suzuki H
Tokyo Research Laboratories Kowa Co. Ltd.:asahi Chemical Industry Co. Ltd.
-
Suzuki Hideo
Tokyo New Drug Research Laboratories I Pharmaceutical Division Kowa Co Ltd
-
Koshi T
Tokyo Research Laboratories Kowa Co. Ltd.
-
Narita Tsutomu
Tokyo Research Laboratories Kowa Co. Ltd.:asahi Chemical Industry Co. Ltd.
-
Kimata Hideki
Tokyo Research Laboratories, Kowa Co. Ltd.
関連論文
- Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (4) : Interspecies Variation in Laboratory Animals and Humans
- Expression of pericyte, mesangium and muscle markers in malignant rhabdoid tumor cell lines : Differentiation-induction using 5-azacytidine
- Malignant rhabdoid tumor shows a unique neural differentiation as distinct from neuroblastoma
- Estrogen Receptor Expression and Estrogen Receptor-independent Cytotoxic Effects of Tamoxifen on Malignant Rhabdoid Tumor Cells in vitro
- The Autocrine Loop of Epidermal Growth Factor Receptor-Epidermal Growth Factor/Transforming Growth Factor-α in Malignant Rhabdoid Tumor Cell Lines:Heterogeneitv of Autocrine Mechanism in TTC549
- Importance of Sialic Acid in Recombinant Thrombomodulin in Terms of Pharmacokinetics and Separation of Desialyzed Glycoprotein
- Increased Anticoagulant Activity of Recombinant Thrombomodulin Modified with Glycosaminoglycan
- Binding of Human Tissue Plasminogen Activator (t-PA) to Blood Clots and Clot-Lytic Activity of Clot-Bound t-PA
- Dehydroxy Substitution Reactions of the Anomeric Hydroxy Groups in Some Protected Sugars Initiated by Anodic Oxidation of Triphenylphosphine
- Fluorination of Secondary and Primary Alcohols by Thermal Decomposition of Electrochemically Generated Alkoxy Triphenylphosphonium Tetrafluoroborates
- Plaque-Stabilizing Effect of Pitavastatin in Watanabe Heritable Hyperlipidemic (WHHL) Rabbits
- Simultaneous determination of NK-104 and its lactone in biological samples by column-switching high-performance liquid chromatography with ultraviolet detection
- Identification of Metabolites of NK-104,an HMG-CoA Reductase Inhibitor, in Rat, Rabbit and Dog Bile
- Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (2) : Absorption, Distribution, Metabolism, Excretion and Accumulation Following Repeated Oral Administration of ^C-NK-104 in Rats
- Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (1) : Absorption, Distribution, Metabolism and Excretion in Rats
- Thrombolytic Effect of Tissue Plasminogen Activator in a Cerebral Embolic Model
- Localization of Tissue Plasminogen Activator on Experimental Microthrombi in Rats. Microautoradiographic Observations
- Localization of Tissue Plasminogen Activator on Experimental Thrombi in Rats
- Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase (3) : Foeto-placental Transfer and Mammary Excretion after Oral Administration in Rats
- EFFECTS OF DILAZEP ON FIBRINOLYTIC SYSTEM IN ANIMALS. II. ENHANCING EFFECT OF DILAZEP ON PLASMINOGEN ACTIVATOR RELEASE IN THE ISOLATED PERFUSED PIG EAR
- EFFECTS OF DILAZEP ON FIBRINOLYTIC SYSTEM IN ANIMALS. I. ENHANCEMENT OF FIBRINOLYTIC ACTIVITY BY ADMINISTERED DILAZEP IN EX VIVO EXPERIMENT
- Effects of Salt-loading on the Onset of Stroke and the Development of Cerebral Lesions in SHRSP
- Possibility of the Low Defensive Fibrinolysis in SHRSP
- Potential effectiveness of minidose aspirin combined with dilazep in anti-platelet therapy.